United Therapeutics (UTHR) Misses Q3 EPS by 50c, Beats on Revenue
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| United Therapeutics Corp (NASDAQ: UTHR) | Delayed: 608.49 +7.17 (1.19%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $601.32 | 52 Week High | $164.04 | |||
| Open | $583.63 | 52 Week Low | $97.52 | |||
| Day High | $614.23 | P/E | 111.24 | |||
| Day Low | $578.28 | EPS | $5.47 | |||
| Volume | 946,056 | |||||
